[Skip to Content]
[Skip to Content Landing]
October 20, 2008

Eccrine Squamous Syringometaplasia Secondary to Pegylated Liposomal Doxorubicin

Author Affiliations

Copyright 2008 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2008

Arch Dermatol. 2008;144(10):1402-1403. doi:10.1001/archderm.144.10.1402

A 56-year-old woman with a poorly differentiated endometrioid adenocarcinoma and peritoneal carcinomatosis was treated with pegylated liposomal doxorubicin for disease progression. After the second dose (40 mg/m2), she developed an eruption that consisted of erythematous plaques with areas of exfoliation and superficial erosions localized to the axillary and submammary areas (Figure 1), groin, hands, and feet. She did not present with hand-foot syndrome.

First Page Preview View Large
First page PDF preview
First page PDF preview